A Smarter Prescription for Topical Pain
FoamaDerm® enables effective topical analgesia at lower concentrations — backed by peer-reviewed research and University of Alberta clinical data.
Why Prescribe FoamaDerm®?
-
Evidence-Based Efficacy at Lower Doses: Diclofenac compounded in FoamaDerm® demonstrates superior drug release compared to conventional bases and brand products. This means your patients benefit from effective pain relief at concentrations up to 3% — eliminating the need for 5% or 10% formulations used in less efficient bases.
-
Clinically Tested on Real Patients: A University of Alberta study evaluated 2% diclofenac in FoamaDerm® in patients with chronic musculoskeletal pain. Results showed meaningful reductions in pain scores, with a favorable tolerability profile. Click to read the article
-
Another clinical assessment in patients with osteoarthritis of knee showed that diclofenac 2% in FoamaDerm® was associated with clinically meaningful reduction in pain score over the study period, supporting its potential as topical treatment option for localized chronic join pain. Click to read the article
-
Improved Safety Profile: Lower effective concentrations mean reduced systemic exposure and a lower risk of skin irritation — an important consideration for elderly patients or those on multiple medications.
-
Better Adherence = Better Outcomes: Patients prefer FoamaDerm®. The water-based, non-greasy formula is easy to apply, leaves no staining, and fits into any daily routine. Better adherence translates directly to better clinical outcomes.
Prescribing Information
Approved Active Ingredients & Maximum Concentrations:
Active Ingredient Maximum Concentration
Diclofenac Sodium 3%
Ketoprofen 3%
Lidocaine HCl 3%
Menthol 1%
Ketamine 4%
Amitriptyline 2%
Combinations beyond those listed below have not been studied. Higher concentrations are not recommended, as they may compromise formulation stability.
Tested combinations:
Diclofenac 3% + Lidocaine 1% or 2%
Ketoprofen 3% + Lidocaine 1% or 2%
Diclofenac 3% + Menthol 1%
Ketoprofen 3% + Menthol1%
Ketamine 2% + Lidocaine 1%
Ketamine 3% + Lidocaine 1%
Suggested Application:
Apply a small amount of foam to the affected area and gently rub in. Frequency and duration should be guided by clinical judgment and patient response.
FoamaDerm® Prescription Pad
Schedule a meeting with us
Diclofenac release profile from different bases, brand product and FoamaDerm®.
